NCT06376669View on ClinicalTrials.gov

Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 25, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

August 31, 2030

Conditions
Renal Cell Carcinoma
Interventions
RADIATION

Proton Stereotactic Body Radiation therapy (SBRT)

Radiation therapy will consist of 3-5 treatments over 1.5 - 2 weeks

Trial Locations (1)

20016

RECRUITING

Sibley Memorial Hospital, Washington D.C.

All Listed Sponsors
collaborator

Robert L. Sloan Fund for Cancer Research

OTHER

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER